Samsung Bets ₩270B on DNA Market to Expand Galaxy Health Ecosystem

Samsung Electronics has made a major MedTech investment, acquiring a controlling stake in U.S.-based DNA sequencing firm Element Biosciences for approximately ₩270 billion, signaling a deeper push into healthcare.